The field of antisense therapeutics has attracted great interest durin
g the past decade. A large body of literature has recently appeared in
which the antisense mechanism is claimed to be involved and a number
of human clinical trials are underway. Questions regarding the specifi
city of action and side effects of antisense phosphorothioate oligonuc
leotides have arisen simultaneously.